Search results
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 3 days agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 2 days agoUS pharmaceutical company Nabla Bio has secured $26m for generative protein design in a Series A financing round led by Radical Ventures. The round...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 3 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 18 hours agoAlthough KRAS and its links to cancer were discovered decades ago, the characteristics of its protein structure were thought to make it “undruggable”....
Immunotherapy may boost survival after lung cancer surgery
United Press International via Yahoo News· 8 hours agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
After CEO change, Lantheus announces more new C-suite additions - Boston Business Journal
The Business Journals· 8 hours agoJust a few months after Lantheus Holdings Inc. named a new CEO, the Bedford company is bringing in...
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
GenomeWeb News· 10 hours agoOxford BioDynamics said on Thursday that it is collaborating with King's College London to develop prognostic blood-based biomarkers to identify patients most likely to progress to rheumatoid ...
123 New Jersey Students Graduate from Governor’s STEM Scholars
New Jersey Business Magazine· 2 days agoOn Saturday, May 11, 123 New Jersey high school and college students graduated from the Governor’s...
Large Cap Trio for Value, Growth and Yield
MoneyShow via Yahoo Finance· 4 days agoWith a solid economy and a Fed still likely to cut interest rates this year, we believe the dividend yield of 2.6% and forward P/E ratio of 14 on our portfolio holdings are attractive, especially ...
Immunotherapy may boost survival after lung cancer surgery
UPI· 8 hours agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...